Actual Medicinal Product (AMP) - Sunlenca 300mg tablets (Gilead Sciences Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Sunlenca 300mg tablets | Start Date 19-05-2025 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
| Code | Start Date | End Date |
|---|---|---|
| 45152811000001105 | 19-05-2025 |
Parent Products
-
VTMLenacapavir
-
VMPLenacapavir 300mg tablets
-
AMP(Current) Sunlenca 300mg tablets (Gilead...
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 5 tablet | 250000 |